2026
Hannes Linder: Exploring Novel Mechanisms of Immunosuppression in Cancer
Sara Fresnillo Saló: Training the Immune System Against Cancer
Mario Presti: From Acquired Resistance to Immune Escape: Investigating Immune Evasion in Melanoma
2025
Klaire Yixin Fjæstad: Neuroimmune Interface in Cancer: Targeting Beta-adrenergic Signaling to Improve Anti-tumor Immunity
Annina Kurzay: TAM-ing Immunity: Therapeutic Modulation of T cells via TAM Receptor Signalling in Cancer
Thomas Hvidkjær Lisle: Harnessing T-cell reactivity towards tumor microenvironment antigens to combat cancer
Joachim Stoltenborg Granhøj: Understanding the Immunology Behind the Efficacy of TIL Therapy in Patients with Metastatic Melanoma
Thy Viet Luu: On Exercise and Cancer: The Effects of Stress Signaling on T Cell immunity
Tine Juul Monberg: Exploring strategies to improve adoptive cell therapy in the treatment of malignant melanoma and ovarian cancer
2024
Thomas Morgan Hulen: Advances in Adoptive Cell Therapies for Cancer: Discovery, Modification and Production
Anne Rahbech: Pre-clinical examination of functional aspects of T cells for adoptive cell therapy
Rikke Bødker Holmstrøm: Adjuvant immunotherapy in melanoma and management of immunotherapy-induced toxicity
Maria Pérez Penco: TGFβ-derived immune modulatory vaccine: reshaping the tumor microenvironment in pancreatic cancer
Inés Lecoq Molinos: Exploring immune-modulatory vaccines to target immunosuppressive macrophages in the tumor microenvironment.
2023
Aimilia Schina: Computational Approaches for Understanding and Predicting Clinical Outcomes in Cancer Immunotherapy
Pia Aehnlich: Strategies to improve adoptive cell therapy with Vγ9Vδ2 T cells
Cathrine Lund Lorentzen: Peptide vaccines targeting ARG1, IDO and PD-L1 in patients with metastatic solid tumors
Rasmus Erik Johansson Mortensen: Vaccination against TGF-ß: A novel way to modulate the tumor microenvironment
Arianna Draghi: Shedding light on tumor-infiltrating lymphocyte functionality
Mia Aaboe Jørgensen: Modulating tumor immunity with an Arginase 1-based cancer vaccine
2022
Uffe Klausen: Peptide vaccination in chroniclymphoproliferative malignancies
Olivia Lie-Andersen: Identification of Viral and Cancer epitopes using peptide: MHC stability measurements
Christopher Aled Chamberlain: Identification, characterisation, and manipulation of tumour-reactive CD8+ T cells: For immunotherapeutic advancement
Astrid Zedlitz Johansen: YKL-40: A Cancer Target and Biomarker?
Nicolai Grønne Dahlager Jørgernsen: Vaccination against PD-L1
Sofie Kirial Mørk: Exploring therapeutic cancer vaccines in patients with malignant melanoma and prostate cancer
Marie-Louise Thorseth: Collagen Remodeling in Cancer and Its Effects on the Tumor Immune Microenvironment
Jacob Handlos Grauslund: Therapeutic cancer vaccination in patients with Philadelphia-chromosome negative myeloproliferative neoplasms
Kasper Mølgaard Jensen: Metabolic Fitness in T-cell Immunotherapy
Stine Emilie Weis-Banke: Arginase-2 as a target for cancer immune therapy
2021
Anne-Mette Askehøj Rømer: Collagen as a modulator of the tumor immune microenvironment
Marlies Peeters: Towards fitter T cells from costimulation to metabolism
Aishwarya Gokuldass: Profiling cross-talk between tumour cells and tumour-infiltrating lymphocytes (TILs)
Julie Westerlin Kjeldsen: Immune modulatory vaccines targeting IDO and PD-L1 in solid tumours
Anders Handrup Kverneland: Adoptive cell therapy across cancer diagnoses.
Ana Micaela Carnaz Simões: Systemic Immune Suppression in Cancer: The Opposing Roles of Platelets and Exercise
2020
Simone Kloch Bendtsen: Exploring New Targets for Immunotherapy in Cancer
Christina Friese: Characterization of tumor-infiltrating lymphocytes after checkpoint blockade within the tumor microenvironment of tumor fragments
2019
Marie Christine Wulf Westergaard: Characterization of tumor-infiltrating lymphocytes and the tumor microenvironment in patients with ovarian cancer
Sara Ram Pedersen: Characterization of immunoregulatory mechanisms in the tumor microenvironment
Morten Nielsen: In vitro expansion of tumour-infiltrating lymphocytes from sarcoma
Dorota Ewa Kuczek: The immunomodulatory effects of the extracellular matrix
Magnus Pedersen: Adoptive Cell Therapy Regimens with Tumor-Infiltrating Lymphocytes in Ovarian Cancer and Renal Cell Carcinoma
2018
Evelina Martinenaite: Preventing immune inhibition in cancer: characterization of immune responses against immune regulatory proteins
Gitte Holmen Olofsson: Vγ9Vδ2 T cells as cancer cell killers and antigen presenting cells
Troels Holz Borch: Evaluation of immune responses to dendritic cell vaccination and adoptive cell therapy
2017
Morten Orebo Holmström: Targeting the Shared Neoantigens: Potentials of Cancer Immune Therapy in Chronic
Rikke Andersen: Exploiting tumor-infiltrating lymphocytes for the treatment of cancer
Manja Idorn: Genetic Engineering of T cells for Improved Homing to Tumor Site - Optimizing Adoptive Cell Therapy
Shamaila Munir Ahmad: T-cell responses
against PD-L1 protein in cancer patients.
Per Kongsted: Taxane-based chemotherapy and dendritic cell therapy in metastatic castration-resistant prostate cancer.
2015
Jon Bjørn: Ipilimumab in the treatment of metastatic malignant melanoma. Immunological correlates of treatment and combination therapy.
2014
Thomas Mørch Frøsig: Elucidating the immunological effects of 5-Azacytidine treatment in patients with myelodysplastic syndrome and identifying new conditional ligands and T-cell epitopes of relevance in melanoma.
Caroline Hasselbalch Riley: Immunological phenotype in patients with JAK2 V617F-positive chronic myeloproliferative neoplasms. Impact of immune therapy with IFN-alpha.
Mads Duus Hjortsø: T-cell Recognition of Immune Modulatory Molecules in Cancer
Stine Kiær Larsen: Cellular Immune Responses Towards Regulatory Cells
2013
Marco Donia: Methods to improve Adoptive T cell therapy with tumor infiltrating lymphocytes
Rikke Sick Andersen: Dissection of human melanoma specific T-cell immunity by use of combinatorial encoding MHC multimers
Trine Zeeberg Iversen: Immune Modulations during Chemo-Immunotherapy & Novel Vaccine Strategies - In Metastatic Melanoma and Non Small-Cell Lung Cancer
2012
Tania Køllgaard: Immune regulatory cells and polymorphisms in cancer
Eva Ellebæk: Dendritic cell vaccination and adoptive cell therapy in patients with metastatic malignant melanoma
Anne Ortved Gang: Immune modulatory effects of azacytidine and possible implications for immunotherapy
2011
Lotte Engell-Nørregård: Dendritic cell vaccination of patients with metastatic malignant melanoma
Niels Junker: Ex vivo expansion and characterization of tumor infiltrating lymphocyte derived T effector memory cells from malignant melanoma and oral squamous cell carcinoma